Skip to main content

Verónica Villagrasa Araya

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Verónica Villagrasa Araya

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Diego Yeste Fernandez

Diego Yeste Fernandez

Senior researcher
Growth and Development
Read more
Juan Martin Dupraz

Juan Martin Dupraz

P Management and Admin. Project manager
Business Development Unit
Innovation and Technology Transfer Directorate
Read more
Joan Castell Conesa

Joan Castell Conesa

Molecular Medical Imaging
Read more
Raquel Mena Marcos

Raquel Mena Marcos

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.